Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Estimating mutation rates in low-replication experiments

  • Couce, Alejandro
  • Blázquez Gómez, Jesús
Since mutation rate is a key biological parameter, its proper estimation has received great attention for decades. However, instead of the mutation rate, many authors opt for reporting the average mutant frequency, a less meaningful quantity. This is because the standard methods to estimate the mutation rate, derived from the Luria and Delbrück's fluctuation analysis, ideally require high-replication experiments to be applied; a requirement often unattainable due to constraints of time, budget or sample availability. But the main problem with mutant frequency, apart from being less informative, is its poor reproducibility; an especially marked defect when the chosen average is the arithmetic mean. Several authors tried to avoid this by employing other averages (such as the median or the geometric mean) or discarding outliers, though as far as we know nobody has evaluated which method performs best under low-replication settings. Here we use computer simulations to compare the performance of different methods used in low-replication experiments (≤4 cultures). Besides the customary averages of mutant frequency, we also tested two well-known fluctuation methods. Contrary to common practice, our results support that fluctuation methods should be applied in such circumstances, as they perform as well as or better than any average of mutant frequency. In particular, experimentalists will benefit from using MSS maximum likelihood in low-replication experiments because it: (i) provides more reproducible results, (ii) allows for direct estimation of mutation rate and (iii) allows for the application of conventional statistics., This work was supported by grant PI070215 of Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008) and the PAR project (Ref. 241476) from EU 7th Framework Programme. We wish to thank J. Rodríguez-Beltrán, J.R. Guelfo and A. Rodríguez-Rojas for stimulating comments in the early steps of this work. We are also grateful to J.F. Poyatos and A. Rodríguez-Rojas for the helpful proofreading of the manuscript, and to J.W. Drake and an anonymous referee for their valuable suggestions to improve this article., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials

  • Thi, Thuy Do
  • López, Elena
  • Rodríguez-Rojas, Alexandro
  • Rodríguez-Beltrán, Jerónimo
  • Couce, Alejandro
  • Guelfo, Javier R
  • Castañeda-García, Alfredo
  • Blázquez, Jesús
Low concentrations of some antibiotics have been reported to stimulate mutagenesis and recombination, which may facilitate bacterial adaptation to different types of stress, including antibiotic pressure. However, the mutagenic effect of most of the currently used antibiotics remains untested. Furthermore, it is known that in many bacteria, including Escherichia coli, stimulation of mutagenesis is mediated by the SOS response. Thus, blockage or attenuation of this response through the inhibition of RecA has been proposed as a possible therapeutic adjuvant in combined therapy to reduce the ability to generate antibiotic-resistant mutants. The aim of this work was to study the capacity of sublethal concentrations of antimicrobials of different families with different molecular targets to increase the mutant frequency of E. coli, and the effect that inactivation of recA would have on antibiotic-mediated mutagenesis., This work was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III (ISCIII) co-financed by the European Development Regional Fund ‘A way to achieve Europe’ ERDF, the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008) and grant PI070215 from ISCIII and the European Community (PAR, FP7-HEALTH-2009-241476). T. D. T. is the recipient of a JAE predoc fellowship from the CSIC., Peer reviewed